HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: M600157-MCP200v1 5/10/1887    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Glossary Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kobeissy, F. H. Articles by Wang, K. K. W. Search for Related Content PubMed PubMed Citation Articles by Kobeissy, F. H. Articles by Wang, K. K. W. Social Bookmarking                      What's this?

Molecular & Cellular Proteomics 5:1887-1898, 2006.
© 2006 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Other Diseases and Conditions

Novel Differential Neuroproteomics Analysis of Traumatic Brain Injury in Rats^*

Firas H. Kobeissy^,,¶,¶¶, Andrew K. Ottens^,,¶,||, Zhiqun Zhang, Ming Cheng Liu, Nancy D. Denslow^**, Jitendra R. Dave, Frank C. Tortella, Ronald L. Hayes^, and Kevin K. W. Wang^,,

From the Center for Neuroproteomics and Biomarkers Research, Department of Psychiatry and Center for Traumatic Brain Injury Studies, Department of Neuroscience, McKnight Brain Institute of the University of Florida and ^** Departments of Physiological Sciences and Biochemistry and Molecular Biology, University of Florida, Gainesville, Florida 32611 and Department of Neuropharmacology and Molecular Biology, Division of Neurosciences, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910

Approximately two million traumatic brain injury (TBI) incidents occur annually in the United States, yet there are no specific therapeutic treatments. The absence of brain injury diagnostic endpoints was identified as a significant roadblock to TBI therapeutic development. To this end, our laboratory has studied mechanisms of cellular injury for biomarker discovery and possible therapeutic strategies. In this study, pooled naïve and injured cortical samples (48 h postinjury; rat controlled cortical impact model) were processed and analyzed using a differential neuroproteomics platform. Protein separation was performed using combined cation/anion exchange chromatography-PAGE. Differential proteins were then trypsinized and analyzed with reversed-phase LC-MSMS for protein identification and quantitative confirmation. The results included 59 differential protein components of which 21 decreased and 38 increased in abundance after TBI. Proteins with decreased abundance included collapsin response mediator protein 2 (CRMP-2), glyceraldehyde-3-phosphate dehydrogenase, microtubule-associated proteins MAP2A/2B, and hexokinase. Conversely C-reactive protein, transferrin, and breakdown products of CRMP-2, synaptotagmin, and II-spectrin were found to be elevated after TBI. Differential changes in the above mentioned proteins were confirmed by quantitative immunoblotting. Results from this work provide insight into mechanisms of traumatic brain injury and yield putative biochemical markers to potentially facilitate patient management by monitoring the severity, progression, and treatment of injury.

^|| To whom correspondence may be addressed: Dept. of Psychiatry, University of Florida, P. O. Box 100256, Gainesville, FL 32610-0256. Tel.: 352-392-8060; Fax: 352-392-2579; E-mail: aottens{at}mbi.ufl.edu

To whom correspondence may be addressed: Dept. of Psychiatry, University of Florida, P. O. Box 100256, Gainesville, FL 32610-0256. Tel.: 352-392-3681; Fax: 352-392-2579; E-mail: kwang{at}psychiatry.ufl.edu

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				V. Rogemond, C. Auger, P. Giraudon, M. Becchi, N. Auvergnon, M.-F. Belin, J. Honnorat, and M. Moradi-Ameli Processing and Nuclear Localization of CRMP2 during Brain Development Induce Neurite Outgrowth Inhibition J. Biol. Chem., May 23, 2008; 283(21): 14751 - 14761. [Abstract] [Full Text] [PDF]